埃博拉病-话题@MedSci - 梅斯（MedSci）

#埃博拉病#

106篇内容 | 2710人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1650301, encodeId=3aee1650301e1, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, objectTitle=世卫预测未来数月埃博拉病例数将超2万, objectType=article, longId=40722, objectId=3ebf40e22a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ebf40e22a6, replyNumber=0, likeNumber=66, createdTime=2015-02-13, rootId=0, userName=tcm107hq, userId=639b24003788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ebf40e22a6, moduleTitle=世卫预测未来数月埃博拉病例数将超2万, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3ebf40e22a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650317, encodeId=2b42165031eba, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, objectTitle=JAMA：消除埃博拉病毒，保障未来--美国总统的国家安全议程, objectType=article, longId=43068, objectId=7f094306875, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f094306875, replyNumber=0, likeNumber=88, createdTime=2015-07-04, rootId=0, userName=tcm107hq, userId=639b24003788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f094306875, moduleTitle=JAMA：消除埃博拉病毒，保障未来--美国总统的国家安全议程, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7f094306875)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650316, encodeId=1ffa16503164a, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, objectTitle=Antiviral Res：T-705抑制剂可成功治疗早期埃博拉病毒感染, objectType=article, longId=43035, objectId=1f9e4303574, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f9e4303574, replyNumber=0, likeNumber=82, createdTime=2014-12-28, rootId=0, userName=tcm107hq, userId=639b24003788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f9e4303574, moduleTitle=Antiviral Res：T-705抑制剂可成功治疗早期埃博拉病毒感染, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1f9e4303574)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650314, encodeId=ffb7165031433, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, objectTitle=Science：埃博拉病毒基因组学发展受阻碍, objectType=article, longId=42573, objectId=4a9f425e3ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a9f425e3ea, replyNumber=0, likeNumber=78, createdTime=2015-01-22, rootId=0, userName=tcm107hq, userId=639b24003788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a9f425e3ea, moduleTitle=Science：埃博拉病毒基因组学发展受阻碍, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4a9f425e3ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650324, encodeId=f4ac1650324b8, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, objectTitle=埃博拉病毒发现者：疫情或将再持续一年, objectType=article, longId=44792, objectId=1a5e44e9292, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a5e44e9292, replyNumber=0, likeNumber=56, createdTime=2015-09-29, rootId=0, userName=tcm107hq, userId=639b24003788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a5e44e9292, moduleTitle=埃博拉病毒发现者：疫情或将再持续一年, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1a5e44e9292)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650313, encodeId=f3f1165031385, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, objectTitle=Mol Pharmac：人类有望利用鼻腔喷雾疫苗来抵御埃博拉病毒的感染, objectType=article, longId=42470, objectId=f776424e0bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f776424e0bf, replyNumber=0, likeNumber=51, createdTime=2015-08-24, rootId=0, userName=tcm107hq, userId=639b24003788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f776424e0bf, moduleTitle=Mol Pharmac：人类有望利用鼻腔喷雾疫苗来抵御埃博拉病毒的感染, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f776424e0bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650306, encodeId=d8451650306e8, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, objectTitle=中国疾控中心出书漫画解读埃博拉病毒被打败, objectType=article, longId=41679, objectId=b33b416e9cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b33b416e9cb, replyNumber=0, likeNumber=82, createdTime=2015-06-30, rootId=0, userName=tcm107hq, userId=639b24003788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b33b416e9cb, moduleTitle=中国疾控中心出书漫画解读埃博拉病毒被打败, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b33b416e9cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650320, encodeId=a6f1165032060, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, objectTitle=ESTL：埃博拉病毒在环境中究竟可以存活多久？无人知晓, objectType=article, longId=44060, objectId=c15644060d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c15644060d4, replyNumber=0, likeNumber=104, createdTime=2015-04-11, rootId=0, userName=tcm107hq, userId=639b24003788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c15644060d4, moduleTitle=ESTL：埃博拉病毒在环境中究竟可以存活多久？无人知晓, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c15644060d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650334, encodeId=3f49165033468, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, objectTitle=PLOS MED：埃博拉病毒临床疗法评价新方法, objectType=article, longId=50104, objectId=3b9b501046e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b9b501046e, replyNumber=0, likeNumber=62, createdTime=2015-07-09, rootId=0, userName=tcm107hq, userId=639b24003788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b9b501046e, moduleTitle=PLOS MED：埃博拉病毒临床疗法评价新方法, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3b9b501046e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650293, encodeId=627f165029316, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, objectTitle=美国感染埃博拉病毒2名医生接受实验性药物ZMapp治疗, objectType=article, longId=38701, objectId=73d538e01bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73d538e01bb, replyNumber=0, likeNumber=60, createdTime=2015-03-28, rootId=0, userName=tcm107hq, userId=639b24003788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73d538e01bb, moduleTitle=美国感染埃博拉病毒2名医生接受实验性药物ZMapp治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=73d538e01bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650337, encodeId=4358165033e13, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, objectTitle=mBio：研究发现埃博拉病毒的致命弱点, objectType=article, longId=51285, objectId=632451285e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=632451285e8, replyNumber=0, likeNumber=64, createdTime=2015-05-31, rootId=0, userName=tcm107hq, userId=639b24003788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=632451285e8, moduleTitle=mBio：研究发现埃博拉病毒的致命弱点, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=632451285e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650325, encodeId=d56c16503252b, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, objectTitle=NEJM：埃博拉病毒感染临床表现及致死率研究, objectType=article, longId=44920, objectId=e38044920ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e38044920ba, replyNumber=0, likeNumber=84, createdTime=2015-11-09, rootId=0, userName=tcm107hq, userId=639b24003788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e38044920ba, moduleTitle=NEJM：埃博拉病毒感染临床表现及致死率研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e38044920ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650302, encodeId=c5ab16503027c, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, objectTitle=HO称明年1月或小范围试用埃博拉病毒疫苗, objectType=article, longId=40990, objectId=567040990fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=567040990fe, replyNumber=0, likeNumber=87, createdTime=2015-06-25, rootId=0, userName=tcm107hq, userId=639b24003788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=567040990fe, moduleTitle=HO称明年1月或小范围试用埃博拉病毒疫苗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=567040990fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650295, encodeId=be301650295a7, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, objectTitle=葛兰素史克开发埃博拉病毒疫苗即将进入临床阶段, objectType=article, longId=39217, objectId=66243921e09, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66243921e09, replyNumber=0, likeNumber=55, createdTime=2014-11-12, rootId=0, userName=tcm107hq, userId=639b24003788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66243921e09, moduleTitle=葛兰素史克开发埃博拉病毒疫苗即将进入临床阶段, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=66243921e09)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650304, encodeId=136a16503046c, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, objectTitle=Lancet：有关埃博拉病人的随机对照试验的争议, objectType=article, longId=41237, objectId=a8874123ef8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8874123ef8, replyNumber=0, likeNumber=69, createdTime=2015-03-16, rootId=0, userName=tcm107hq, userId=639b24003788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8874123ef8, moduleTitle=Lancet：有关埃博拉病人的随机对照试验的争议, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a8874123ef8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650322, encodeId=0d0516503222f, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, objectTitle=孙学军：抗埃博拉病毒被迫启用百年老方是医学的尴尬, objectType=article, longId=44696, objectId=1ca3446960e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ca3446960e, replyNumber=0, likeNumber=79, createdTime=2015-09-24, rootId=0, userName=tcm107hq, userId=639b24003788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ca3446960e, moduleTitle=孙学军：抗埃博拉病毒被迫启用百年老方是医学的尴尬, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1ca3446960e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650332, encodeId=d49b165033250, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, objectTitle=Science：埃博拉病毒变异没有人们想象的那么快, objectType=article, longId=48745, objectId=dc3448e4512, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc3448e4512, replyNumber=0, likeNumber=53, createdTime=2015-09-01, rootId=0, userName=tcm107hq, userId=639b24003788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc3448e4512, moduleTitle=Science：埃博拉病毒变异没有人们想象的那么快, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=dc3448e4512)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650329, encodeId=3bde165032936, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, objectTitle=埃博拉病毒病在西非：世纪的哭泣, objectType=article, longId=46368, objectId=bcd546368c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bcd546368c2, replyNumber=0, likeNumber=93, createdTime=2015-03-05, rootId=0, userName=tcm107hq, userId=639b24003788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bcd546368c2, moduleTitle=埃博拉病毒病在西非：世纪的哭泣, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=bcd546368c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650312, encodeId=2d8f165031261, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, objectTitle=NEJM：几内亚科纳克里地区埃博拉病毒感染者的临床表现, objectType=article, longId=42269, objectId=c37d42269c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c37d42269c0, replyNumber=0, likeNumber=85, createdTime=2015-08-17, rootId=0, userName=tcm107hq, userId=639b24003788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c37d42269c0, moduleTitle=NEJM：几内亚科纳克里地区埃博拉病毒感染者的临床表现, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c37d42269c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650319, encodeId=73b216503197c, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, objectTitle=Science：多种抗埃博拉病毒药物相继开展临床试验, objectType=article, longId=43733, objectId=3d0843e3381, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d0843e3381, replyNumber=0, likeNumber=93, createdTime=2015-09-21, rootId=0, userName=tcm107hq, userId=639b24003788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d0843e3381, moduleTitle=Science：多种抗埃博拉病毒药物相继开展临床试验, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3d0843e3381)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

埃博拉病

2020-05-29

tcm107hq (审核中...)

前往app查看评论内容

#埃博拉病#

世卫预测未来数月埃博拉病例数将超2万

2015-02-13

tcm107hq (审核中...)

前往app查看评论内容

#埃博拉病#

JAMA：消除埃博拉病毒，保障未来--美国总统的国家安全议程

2015-07-04

tcm107hq (审核中...)

前往app查看评论内容

#埃博拉病#

Antiviral Res：T-705抑制剂可成功治疗早期埃博拉病毒感染

2014-12-28

tcm107hq (审核中...)

前往app查看评论内容

#埃博拉病#

Science：埃博拉病毒基因组学发展受阻碍

2015-01-22

tcm107hq (审核中...)

前往app查看评论内容

#埃博拉病#

埃博拉病毒发现者：疫情或将再持续一年

2015-09-29

tcm107hq (审核中...)

前往app查看评论内容

#埃博拉病#

Mol Pharmac：人类有望利用鼻腔喷雾疫苗来抵御埃博拉病毒的感染

2015-08-24

tcm107hq (审核中...)

前往app查看评论内容

#埃博拉病#

中国疾控中心出书漫画解读埃博拉病毒被打败

2015-06-30

tcm107hq (审核中...)

前往app查看评论内容

#埃博拉病#

ESTL：埃博拉病毒在环境中究竟可以存活多久？无人知晓

2015-04-11

tcm107hq (审核中...)

前往app查看评论内容

#埃博拉病#

PLOS MED：埃博拉病毒临床疗法评价新方法

2015-07-09

tcm107hq (审核中...)

前往app查看评论内容

#埃博拉病#

美国感染埃博拉病毒2名医生接受实验性药物ZMapp治疗

2015-03-28

tcm107hq (审核中...)

前往app查看评论内容

#埃博拉病#

mBio：研究发现埃博拉病毒的致命弱点

2015-05-31

tcm107hq (审核中...)

前往app查看评论内容

#埃博拉病#

NEJM：埃博拉病毒感染临床表现及致死率研究

2015-11-09

tcm107hq (审核中...)

前往app查看评论内容

#埃博拉病#

HO称明年1月或小范围试用埃博拉病毒疫苗

2015-06-25

tcm107hq (审核中...)

前往app查看评论内容

#埃博拉病#

葛兰素史克开发埃博拉病毒疫苗即将进入临床阶段

2014-11-12

tcm107hq (审核中...)

前往app查看评论内容

#埃博拉病#

Lancet：有关埃博拉病人的随机对照试验的争议

2015-03-16

tcm107hq (审核中...)

前往app查看评论内容

#埃博拉病#

孙学军：抗埃博拉病毒被迫启用百年老方是医学的尴尬

2015-09-24

tcm107hq (审核中...)

前往app查看评论内容

#埃博拉病#

Science：埃博拉病毒变异没有人们想象的那么快

2015-09-01

tcm107hq (审核中...)

前往app查看评论内容

#埃博拉病#

埃博拉病毒病在西非：世纪的哭泣

2015-03-05

tcm107hq (审核中...)

前往app查看评论内容

#埃博拉病#

NEJM：几内亚科纳克里地区埃博拉病毒感染者的临床表现

2015-08-17

tcm107hq (审核中...)

前往app查看评论内容

#埃博拉病#

Science：多种抗埃博拉病毒药物相继开展临床试验

2015-09-21

科室
- - 订阅+
  - 更多科室
工具
服务